Staff editor

Dietary fiber, bloutia, and mucus function: uncovering potential for Next-Generation Probiotics

The interview with Björn O. Schröder from Umeå University explores groundbreaking research on the gut mucus layer, which shields intestinal tissues from bacterial invasion and inflammation.

EnteroBiotix’s EBX-102 shows promising Phase 1b results for liver cirrhosis treatment

New microbiome based therapy demonstrates safety and potential benefits for liver cirrhosis and mental health.

October 2024 review: M&A, licensing, and investments in one place

October 2024 saw notable activity in mergers, acquisitions, and strategic investments within the biotech and life sciences industries.

The impact of food additives on the microbiome: pathways to personalized health

Benoit Chassaing from institute Pasteur (France), delves into the ways various environmental factors, particularly dietary additives, affect the gut microbiome. 

Codex Committee on Nutrition and Foods for Special Dietary Uses Concludes 44th Session without Adopting Probiotic Guidelines

In the session's conclusion, CCNFSDU agreed to maintain the status quo for the next three to five years rather than start to work on new guidelines.

Connecting the dots: nutrition, microbiota, metabolism. Key takeaways from Ri.MED Symposium 2024

In a recent Symposium chaired by Giulio Superti-Furga (The Ri.med Foundation), experts gathered to explore groundbreaking research at the intersection of nutrition, microbiota, and human health. 

Artificial intelligence and multi-omic analysis: new frontiers in biomedical research

Microbiomepost conducted an exclusive interview with engineer Corrado Vecchi, representing Ebris, who discussed the role of artificial intelligence (AI) in processing complex data generated from multi-omic studies.

The gut, conductor of our health. The International Yakult Symposium congress report  

A symphony of microbiome insights: from early infancy to advanced age, the microbiome orchestrates critical processes that affect our health.

Gut dysbiosis and cancer: new insights into immunotherapy resistance and patient survival

Microbiomepost discussed with Lisa Derosa, oncologist at Gustave Roussy Hospital in Paris, about the link between gut dysbiosis and cancer, shedding light on its role in immunotherapy resistance and patient…

Supporting women’s health through menopause: probiotic insights from IFF Health

Exploring probiotics for menopause with Maider Gutierrez, Business Development Lead for Women’s Health & Healthy Aging, IFF Health: solutions to support women's health and manage symptoms effectively.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.